The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Systemic inflammation, nutritional status and survival in patients with cancer
Abstract
PURPOSE OF REVIEW: There is now good evidence in humans that a chronic systemic inflammatory response results in the cardinal features of cancer cachexia, principally the progressive loss of weight (in particular lean tissue). This review examines the role of recent simple objective systemic inflammation-based scores in predicting reduction of nutritional status and survival. RECENT FINDINGS: The most common measure of the systemic inflammatory response in cancer patients has been an elevated C-reactive protein concentration. This has now been included in recent definitions of cancer cachexia. There are also recent systemic inflammation-based scores, the Glasgow Prognostic Score, Neutrophil Lymphocyte Ratio and the Platelet Lymphocyte Ratio that have been shown to have prognostic value in cancer patients. These scores, in particular the Glasgow Prognostic Score, enable identification of patients who are, or likely, to develop cachexia, have a poor response to treatment and who are likely to have poor survival. SUMMARY: A chronic systemic inflammatory response is clearly implicated in the progressive nutritional and functional decline in the cancer patients and their subsequent poor outcome. Systemic inflammation-based prognostic scores not only identify patients at risk but also provide well defined therapeutic targets for future clinical trials targeting nutritional decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
Walsh, S. R., Cook, E. J., Goulder, F., Justin, T. A., & Keeling, N. J. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20329 · Cited by 894
Forrest, L. M., McMillan, D. C., McArdle, C. S., Angerson, W. J., & Dunlop, D. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601242 · Cited by 792
Self-citationCachexia: pathophysiology and clinical relevance1,2
Morley, J. E., Thomas, D. R., & Wilson, M.-M. G. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.735 · Cited by 786
Fearon, K. C., Voss, A. C., & Hustead, D. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1345 · Cited by 779
McMillan, D. C., Crozier, J. E. M., Canna, K., Angerson, W. J., & McArdle, C. S. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0259-6 · Cited by 533
Self-citationCho, H., Hur, H. W., Kim, S. W., Kim, S. H., Kim, J. H., Kim, Y. T., & Lee, K. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0516-3 · Cited by 529
McMillan, D. C. (2008) · Proceedings of the Nutrition Society · doi:10.1017/s0029665108007131 · Cited by 472
Self-citationYamanaka, T., Matsumoto, S., Teramukai, S., Ishiwata, R., Nagai, Y., & Fukushima, M. (2007) · Oncology · doi:10.1159/000127412 · Cited by 454
Halazun, K. J., Aldoori, A., Malik, H. Z., Al-Mukhtar, A., Prasad, K. R., Toogood, G. J., & Lodge, J. P. A. (2008) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2007.02.014 · Cited by 444
Cited by
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., McCargar, L. J., Murphy, R., Ghosh, S., Sawyer, M. B., & Baracos, V. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2722 · Cited by 2,680
Hu, B., Yang, X.-R., Xu, Y., Sun, Y.-F., Sun, C., Guo, W., Zhang, X., Wang, W.-M., Qiu, S.-J., Zhou, J., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0442 · Cited by 2,493
McMillan, D. C. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.08.003 · Cited by 1,398
Self-citationRoxburgh, C. S., & McMillan, D. C. (2010) · Future Oncology · doi:10.2217/fon.09.136 · Cited by 998
Self-citationProctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., Fletcher, C. D., O’Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.028 · Cited by 757
Self-citationProctor, M. J., Morrison, D. S., Talwar, D., Balmer, S. M., O'Reilly, D. S. J., Foulis, A. K., Horgan, P. G., & McMillan, D. C. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606087 · Cited by 531
Self-citationChua, W., Charles, K. A., Baracos, V. E., & Clarke, S. J. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.100 · Cited by 468
Pinato, D. J., North, B. V., & Sharma, R. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.92 · Cited by 421
Smith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · Clinical Science · doi:10.1042/cs20100597 · Cited by 372
Dolan, R. D., McSorley, S. T., Horgan, P. G., Laird, B., & McMillan, D. C. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.06.002 · Cited by 351
Self-citationThe neutrophil-to-lymphocyte ratio: a narrative review
Socorro Faria, S., Fernandes Jr, P. C., Barbosa Silva, M. J., Lima, V. C., Fontes, W., Freitas-Junior, R., Eterovic, A. K., & Forget, P. (2016) · ecancermedicalscience · doi:10.3332/ecancer.2016.702 · Cited by 332
Prognostic Value of PLR in Various Cancers: A Meta-Analysis
Zhou, X., Du, Y., Huang, Z., Xu, J., Qiu, T., Wang, J., Wang, T., Zhu, W., & Liu, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101119 · Cited by 330
Hong, X., Cui, B., Wang, M., Yang, Z., Wang, L., & Xu, Q. (2015) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.236.297 · Cited by 326
Paramanathan, A., Saxena, A., & Morris, D. L. (2014) · Surgical Oncology · doi:10.1016/j.suronc.2013.12.001 · Cited by 316
Kao, S. C. H., Pavlakis, N., Harvie, R., Vardy, J. L., Boyer, M. J., van Zandwijk, N., & Clarke, S. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2245 · Cited by 316
Aapro, M., Arends, J., Bozzetti, F., Fearon, K., Grunberg, S. M., Herrstedt, J., Hopkinson, J., Jacquelin-Ravel, N., Jatoi, A., Kaasa, S., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu085 · Cited by 308
Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer
Howard, R., Kanetsky, P. A., & Egan, K. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-56218-z · Cited by 296
Cedrés, S., Torrejon, D., Martínez, A., Martinez, P., Navarro, A., Zamora, E., Mulet-Margalef, N., & Felip, E. (2012) · Clinical and Translational Oncology · doi:10.1007/s12094-012-0872-5 · Cited by 293
Arrieta, O., Michel Ortega, R. M., Villanueva-Rodríguez, G., Serna-Thomé, M. G., Flores-Estrada, D., Diaz-Romero, C., Rodríguez, C. M., Martínez, L., & Sánchez-Lara, K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-50 · Cited by 284
Cancer Cachexia: Mechanisms and Clinical Implications
Donohoe, C. L., Ryan, A. M., & Reynolds, J. V. (2011) · Gastroenterology Research and Practice · doi:10.1155/2011/601434 · Cited by 273
Cancer cachexia—pathophysiology and management
Suzuki, H., Asakawa, A., Amitani, H., Nakamura, N., & Inui, A. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0787-0 · Cited by 268
Cachexia in patients with oesophageal cancer
Anandavadivelan, P., & Lagergren, P. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.200 · Cited by 262
Inflammation and Cancer: Causes and Consequences
Moore, M. M., Chua, W., Charles, K. A., & Clarke, S. J. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.254 · Cited by 258
Intravenous vitamin C in the supportive care of cancer patients: A review and rational approach
Klimant, E., Wright, H., Rubin, D., Seely, D., & Markman, M. (2018) · Current Oncology · doi:10.3747/co.25.3790 · Cited by 99
Kim, M.-R., Kim, A.-S., Choi, H.-I., Jung, J.-H., Park, J. Y., & Ko, H.-J. (2020) · PLOS ONE · doi:10.1371/journal.pone.0236445 · Cited by 76
Jamieson, N. B., Mohamed, M., Oien, K. A., Foulis, A. K., Dickson, E. J., Imrie, C. W., Carter, C. R., McKay, C. J., & McMillan, D. C. (2012) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2370-y · Cited by 60
Self-citationChen, L., Yang, Q., Zhang, H., Wan, L., Xin, B., Cao, Y., Zhang, J., & Guo, C. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113066 · Cited by 39
Mahiat, C., Bihin, B., Duplaquet, F., Stanciu Pop, C., Dupont, M., Vander Borght, T., Rondelet, B., Vanderick, J., André, B., Pirard, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043618 · Cited by 23
“It is now well established that systemic inflammation plays a critical role in many phases of cancer development, influences responses to therapies, and is involved in cancer cachexia, which is itself a poor prognostic factor [24,48].”
Dolan, R. D., Maclay, J. D., Abbass, T., Colville, D., Buali, F., MacLeod, N., McSorley, S. T., Horgan, P. G., & McMillan, D. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-77269-7 · Cited by 22
Self-citation
Metadata
- Authors
- McMillan, D. C.
- Venue
- Current Opinion in Clinical Nutrition and Metabolic Care
- Published
- 2009-05
- Volume
- 12
- Issue
- 3
- Pages
- 223-226
- ISSN
- 1363-1950 (ISSN-L)
- OpenAlex
- W2091553144
- Cited by
- 1,001
- References
- 32
- FWCI
- 15.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.